Drug Database
Back to search

Belgium· BE-AMP-SAM168901-00

Myoview 230 µg

A 99mtc-technetium-tetrofosmin product containing tetrofosmin, registered in Belgium by GE Healthcare. The same ATC class is registered in 8 of our 19 countries.

ATC V09GA02

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMyoview 230 µgATCV09GA02REGISTER NO.BE-AMP-SAM168901-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tetrofosminAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

99mtc-technetium-tetrofosmin is registered in 8 of 19 countries.

Countries holding a registration under ATC V09GA02 (99mtc-technetium-tetrofosmin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search 99mtc-technetium-tetrofosmin products by name

99mtc-technetium-tetrofosmin · ATC V09GA02

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Tetrofosmin
Manufacturer
GE Healthcare
Country
Belgium (BE)
ATC code
V09GA02
ATC class
99mTc-Technetium-Tetrofosmin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    3338241
  • be_apb
    3338233

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for 99mtc-technetium-tetrofosmin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check 99mtc-technetium-tetrofosmin against other medicinesHow interaction checks work

99mtc-technetium-tetrofosmin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • Amyl nitriteV03AB22moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

99mtc-technetium-tetrofosmin in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All 99mtc-technetium-tetrofosmin products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Myoview, Tetrofosmin Rotop
  • Bulgaria · Майовю
  • Cyprus · Myoview
  • Czechia · Myoview
  • Germany · Myoview, Tetrofosmin Rotop
  • Denmark · Myoview
  • Spain · Myoview, Tetrofosmina Rotop
  • Finland · Myoview, Tetrofosmin Rotop
  • France · Myoview
  • United Kingdom (Northern Ireland) · Myoview, Tetrofosmin Rotop
  • Greece · Myoview, Tetrofosmin Rotop
  • Hungary · Myoview
  • Ireland · Myoview
  • Italy · Myoview
  • Luxembourg · Myoview
  • Malta · Myoview
  • Netherlands · Myoview, Tetrofosmine Rotop
  • Norway · Myoview
  • Portugal · Myoview, Tetrofosmina Rotop
  • Sweden · Myoview, Tetrofosmin Rotop
  • Slovakia · Myoview

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bdb205aa-6e0f-4574-aba1-976ed5253df1
GET /v1/drugs/bdb205aa-6e0f-4574-aba1-976ed5253df1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kit for radiopharmaceutical preparation",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Myoview 230 µg",
  "name_fr": "Myoview 230 µg",
  "name_nl": "Myoview 230 µg",
  "amp_code": "SAM168901-00",
  "strengths": [
    "0.2300",
    "0.3200",
    "1.0000",
    "1.8000"
  ],
  "pack_count": 2,
  "substances": [
    "Tetrofosmin",
    "Disodium Sulfosalicylate",
    "Sodium Gluconate",
    "Sodium Hydrogen Carbonate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Technetium (99mTc) Tetrofosmin",
  "authorisation_numbers": [
    "BE168901"
  ]
}
API referenceMCP serverPlans

See everything about 99mtc-technetium-tetrofosmin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console